June 22, 2017 8:02 PM ET

Pharmaceuticals

Company Overview of Dermira, Inc.

Key Executives for Dermira, Inc.

NameBoard RelationshipsTitleAge
Thomas G. Wiggans 150 RelationshipsCo-Founder, Chairman and Chief Executive Officer64
Eugene Andrew Bauer M.D.71 RelationshipsCo-Founder, Chief Medical Officer and Director 74
Christopher M. Griffith No RelationshipsCo-Founder and Senior Vice President of Corporate Development & Strategy40
Andrew L. Guggenhime No RelationshipsChief Financial Officer and Chief Operating Officer48
Christine R. Conroy Pharm. D.No RelationshipsSenior Vice President for Regulatory Affairs55
View More Key Executives

Dermira, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas G. Wiggans 150 RelationshipsDermira, Inc.64
Eugene Andrew Bauer M.D. 71 RelationshipsDermira, Inc.74
Frederick B. Craves Ph.D. 132 RelationshipsBay City Capital LLC70
Jake R. Nunn CFA 47 RelationshipsNew Enterprise Associates46
David Eric Cohen M.D., M.P.H 51 RelationshipsDermira, Inc.51
View All Board Members

Dermira, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Matthew K. Fust39 Relationships2 Executives
Compensation Committee Ph.D.Frederick B. Craves132 Relationships2 Executives
Nominating Committee CFAJake R. Nunn47 Relationships3 Executives
Corporate Governance Committee CFAJake R. Nunn47 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$500.0K
500.0K
409.0K
Bonus$21.4M
Not meaningful
Total Short Term Compensation$500.0K
500.0K
576.2K
Total Value of Options
8.4M
Compensation as of Fiscal Year
Dermira, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Relmada Therapeutics, Inc. Announces Appointments of Dr. Ottavio Vitolo as Executive Clinical Advisor
June 21, 2017 12:00 PM ET
Lupin Appoints Pooja Thakran as Head - Corporate Communications
June 21, 2017 10:30 AM ET
Eisai Co., Ltd. Approves Appointment of Directors
June 21, 2017 8:42 AM ET
Nanotherapeutics, Inc. Appoints Peter H. Khoury as President and Chief Executive Officer
June 20, 2017 12:33 PM ET
Blade Therapeutics Appoints Ramona Doyle as Chief Medical Officer and Prabha Ibrahim as Chief Technology Officer
June 20, 2017 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dermira, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.